# Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain

> **NCT02324166** · PHASE4 · UNKNOWN · sponsor: **University Health Network, Toronto** · enrollment: 54 (estimated)

## Conditions studied

- Vitreoretinal Surgery
- Endophthalmitis

## Interventions

- **DRUG:** Cefazolin
- **DRUG:** Lidocaine

## Key facts

- **NCT ID:** NCT02324166
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2015-01
- **Primary completion:** 2016-01
- **Final completion:** 2016-01
- **Target enrollment:** 54 (ESTIMATED)
- **Last updated:** 2014-12-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02324166

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02324166, "Cefazolin-Lidocaine Combination Solution to Reduce Antibiotic Pain". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT02324166. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*